论文部分内容阅读
目的:探讨慢性心力衰竭心功能Ⅲ~Ⅳ级患者,循证治疗佐以低分子肝素治疗的近期疗效。方法:对近3 a来符合条件的住院患者100例,随机分成抗凝组和非抗凝组各50例,对两组疗效进行统计分析。结果:抗凝组显效率、总有效率与对照组比较均有统计学意义;栓塞并发症减少;无不良反应。结论:慢性心力衰竭心功能Ⅲ~Ⅳ级患者,在循证治疗的基础上,佐以抗凝治疗,疗效显著,栓塞发生率下降,无出血等不良反应。
Objective: To investigate the short-term curative effect of evidence-based therapy combined with low molecular weight heparin in patients with grade Ⅲ ~ Ⅳ cardiac function in patients with chronic heart failure. Methods: 100 hospitalized patients who met the criteria in the past 3 years were randomly divided into anticoagulation group and non-anticoagulation group, 50 cases each. The curative effect of the two groups were statistically analyzed. Results: The effective rate and the total effective rate of the anticoagulation group were statistically significant compared with the control group. The embolic complications were reduced and no adverse reactions were observed. Conclusion: The patients with grade Ⅲ ~ Ⅳ cardiac function in chronic heart failure are treated with anticoagulant therapy on the basis of evidence - based therapy. The curative effect is significant, the incidence of embolism is reduced, and no adverse reactions such as bleeding are found.